Drug interactions
Bazedoxifene-conjugated estrogens + Lonapegsomatropin
Severity: Moderate
Bazedoxifene-conjugated estrogens and Lonapegsomatropin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Oral estrogens reduce the hepatic production of IGF-1 in response to growth hormone, so the biological effect of lonapegsomatropin may be blunted. Patients may need a higher growth hormone dose to reach their IGF-1 target.
What this interaction means in plain words
Bazedoxifene-conjugated estrogens and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Bazedoxifene-conjugated estrogens belongs to Endocrine; Lonapegsomatropin belongs to Endocrine.
Why it happens
Oral estrogen exposure of the liver suppresses growth hormone-induced IGF-1 generation, causing partial growth hormone resistance.
What to do
Monitor serum IGF-1 and clinical response when starting or stopping the estrogen-containing product, and titrate lonapegsomatropin dose accordingly.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Bazedoxifene-conjugated estrogens and Lonapegsomatropin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Bazedoxifene-conjugated estrogens
- Anastrozole + Bazedoxifene-conjugated estrogens Contraindicated
- Bazedoxifene-conjugated estrogens + Ospemifene Contraindicated
- Antithrombin alfa + Bazedoxifene-conjugated estrogens Major
- Antithrombin iii + Bazedoxifene-conjugated estrogens Major
- Bazedoxifene-conjugated estrogens + Bemiparin Major
- Bazedoxifene-conjugated estrogens + Carbamazepine Major
Other interactions of Lonapegsomatropin
- Alogliptin-metformin + Lonapegsomatropin Moderate
- Alogliptin-pioglitazone + Lonapegsomatropin Moderate
- Alogliptin + Lonapegsomatropin Moderate
- Canagliflozin + Lonapegsomatropin Moderate
- Chlorpropamide + Lonapegsomatropin Moderate
- Cyclosporin + Lonapegsomatropin Moderate
Frequently asked questions
Can I take Bazedoxifene-conjugated estrogens with Lonapegsomatropin?
MediHelp rates the interaction as moderate. Bazedoxifene-conjugated estrogens and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Oral estrogens reduce the hepatic production of IGF-1 in response to growth hormone, so the biological effect of lonapegsomatropin may be blunted. Patients may need a higher growth hormone dose to reach their IGF-1 target.
How serious is the interaction between Bazedoxifene-conjugated estrogens and Lonapegsomatropin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum IGF-1 and clinical response when starting or stopping the estrogen-containing product, and titrate lonapegsomatropin dose accordingly.
What other medicines interact with Bazedoxifene-conjugated estrogens?
MediHelp also lists interactions of Bazedoxifene-conjugated estrogens with, for example, Anastrozole, Ospemifene, Antithrombin alfa. The full list is on the Bazedoxifene-conjugated estrogens page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
